Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11980636 Treatment of hematological disorders

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Stefan Faderl0

Date of Patent

May 14, 2024

0

Patent Application Number

175302450

Date Filed

November 18, 2021

0

Patent Citations

US Patent 10927418 Assays and methods for selecting a treatment regimen for a subject with leukemia

0

US Patent 11746386 Assays and methods for selecting a treatment regimen for a subject with leukemia

0

US Patent 7238367 Liposome loading with metal ions

0

US Patent 7744921 Liposome loading with metal ions

0

US Patent 7842676 Fixed ratio drug combination treatments for solid tumors

0

US Patent 7850990 Compositions for delivery of drug combinations

0

US Patent 8022279 Liposomal formulations of anthracycline agents and cytidine analogs

0

US Patent 8092828 Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders

0

...

Patent Primary Examiner

Celeste A Roney

0

Patent abstract

The invention relates to compositions and methods for treating patients with hematological proliferative disorders with CPX-351, a liposomal composition of daunorubicin and cytarabine, and venetoclax.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11980636 Treatment of hematological disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool